Raffles Medical Group Ltd

BSL.SI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BSL.SI stands at 1.9B. In comparison, Q0F.SI has a market cap of 18.1B. Regarding current trading prices, BSL.SI is priced at SGD 1.02, while Q0F.SI trades at SGD 2.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BSL.SI currently has a P/E ratio of 34.00, whereas Q0F.SI's P/E ratio is 25.62. In terms of profitability, BSL.SI's ROE is +0.04%, compared to Q0F.SI's ROE of +0.09%. Regarding short-term risk, BSL.SI is more volatile compared to Q0F.SI. This indicates potentially higher risk in terms of short-term price fluctuations for BSL.SI.

BSL.SI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BSL.SI stands at 1.9B. In comparison, QC7.SI has a market cap of 422.3M. Regarding current trading prices, BSL.SI is priced at SGD 1.02, while QC7.SI trades at SGD 0.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BSL.SI currently has a P/E ratio of 34.00, whereas QC7.SI's P/E ratio is 22.25. In terms of profitability, BSL.SI's ROE is +0.04%, compared to QC7.SI's ROE of +0.14%. Regarding short-term risk, BSL.SI is more volatile compared to QC7.SI. This indicates potentially higher risk in terms of short-term price fluctuations for BSL.SI.

BSL.SI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BSL.SI stands at 1.9B. In comparison, 9G2.SI has a market cap of 30.8M. Regarding current trading prices, BSL.SI is priced at SGD 1.02, while 9G2.SI trades at SGD 0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BSL.SI currently has a P/E ratio of 34.00, whereas 9G2.SI's P/E ratio is -0.97. In terms of profitability, BSL.SI's ROE is +0.04%, compared to 9G2.SI's ROE of -0.38%. Regarding short-term risk, BSL.SI is more volatile compared to 9G2.SI. This indicates potentially higher risk in terms of short-term price fluctuations for BSL.SI.